Hims & Hers Health, Inc. (HIMS) Tops Q1 EPS by 4c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Hims and Hers (HIMS) PT Lowered to $14 at Jefferies
May 7, 2024 4:03 PM EDTJefferies analyst Glen Santangelo lowered the price target on Hims and Hers (NYSE: HIMS) to $14.00 (from $15.00) while maintaining a Hold rating.
The analyst comments "We are updating our model following 1Q results. The updated model reflects the company's impressive profitability ramp... More
Hims and Hers (HIMS) PT Raised to $16 at Deutsche Bank
May 7, 2024 5:24 AM EDTDeutsche Bank analyst George Hill raised the price target on Hims and Hers (NYSE: HIMS) to $16.00 (from $14.00) while maintaining a Hold rating.
The analyst comments "Based on the strong momentum in Q1, management raised the 2024 revenue guidance by $30 million at the... More
